Medical device company IDEXX Laboratories, Inc. (NASDAQ: IDXX) on Monday reported higher revenues and net income for the fourth quarter of 2024.
- Fourth-quarter revenues increased 6% annually to $954.3 million; organic revenue growth was 6%
- Net income attributable to shareholders moved up to $216.1 million in Q4 from $194.5 million a year earlier
- On a per-share basis, fourth-quarter earnings rose to $2.62 from $2.32 in Q4 2023
- For fiscal 2025, the management expects revenues to be in the range of $4.06 billion to $4.17 billion, reflecting a growth of 4-7%
- Full-year organic revenue growth is expected to be between 6% and 9%
- The management is looking for earnings of $11.74 per share to $12.24 per share for FY25, an increase of 10-15% on a reported basis
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
NKE Q2 Earnings Preview: Can Nike maintain the recovery momentum?
Sneaker giant NIKE, Inc. (NYSE: NKE) entered the fiscal year facing heightened competition and shifting consumer preferences. Its upcoming second-quarter results are expected to reflect these evolving industry dynamics and
Earnings Preview: Conagra Brands’ (CAG) sales and earnings projected to decline in Q2 2026
Shares of Conagra Brands, Inc. (NYSE: CAG) rose 1% on Friday. The stock has dropped 7% in the past three months. The branded food company is slated to report its
Costco (COST) reports strong growth in Q1 FY26 earnings; revenue up 8%
Costco Wholesale Corporation (NASDAQ: COST) has reported an increase in net income for the first quarter of fiscal 2026. Revenues grew 8.3% year-over-year. The Issaquah, Washington-headquartered warehouse giant’s total revenues
